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BTT on Hb A2 levels is uncertain.emoglobin (Hb) A2 (22) constitutes less than 3% of the total
emoglobin (Hb) in adults and has almost no physiological
mportance.1 On the other hand, the determination of Hb A2
s an important tool to diagnose the beta-thalassemia trait
BTT).1,2 Although individuals with BTT do not need treat-
ent, the accurate detection of the carrier state is important
n genetic counseling to determine risk of having a child with
 major disease.3
Elevated levels of Hb A2 and microcytosis are suggestive
f the diagnosis of BTT. However, BTT may be present with
ormal levels of Hb A2 as a few cases of -thalassemia are
ot associated with elevated Hb A2, and because of the asso-
iation of BTT with iron deﬁciency or with -thalassemia
-Thal).1,2,4–6 There are many  other factors, inherited or
cquired, that can interfere in Hb A2 levels (Table 1).3,4
Hb A2 can be measured by several laboratorial methods, but
hese methods have differences in accuracy.7 Cation exchange
igh performance liquid chromatography (HPLC), microcol-
mn  chromatography, and cellulose acetate electrophoresis
ith elution are considered acceptable methods to diagnose
TT, whereas cellulose acetate electrophoresis followed by
2canning densitometry is not. The accuracy of cellulose
cetate electrophoresis with elution depends on the train-
ng and experience of the laboratory technician who performs
 See paper by Fonseca et al. on pages 296–301.
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eserved.the test, and microcolumn chromatography can give problems
with co-elution of some Hb variants.7
Recent studies have conﬁrmed the higher quality of auto-
mated HPLC in the measurement of Hb A2 compared to the
other methods,8,9 which is why this has become the method
of choice. On the other hand, in automated HPLC, the mea-
surement of Hb A2 is inaccurate when Hb S is present.2,3,10
As the amount of Hb S is related to the degree of inaccuracy,
levels are higher in patients with sickle cell anemia (SCA) or
Hb S/-thalassemia (S-Thal) than in sickle cell trait.2 Thus,
the amount of Hb A2 does not indicate BTT when Hb A and
beta gene variants are found together.11 Furthermore, when
beta gene variants are present without Hb A, the diagnosis of
concomitant BTT is not necessarily associated to the elevation
of Hb A2 and so further investigations using family studies or
DNA analysis are necessary.10
As mentioned above, -Thal is capable of interfering in the
determination of Hb A2.4 Individuals with the 0-thalassemia
trait or homozygous for +-thalassemia have lower levels of
Hb A2, but the inﬂuence of the coinheritance of -Thal and
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In Brazil, the incidence of -Thal varies from 0.11 to 0.22%
depending on the geographical region studied.12–15 It is well
known that the association of -Thal and SCA is common in
 e Terapia Celular. Published by Elsevier Editora Ltda. All rights
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Table 1 – Causes of variation in the percentage of
hemoglobin A2.
Hb A2 Inherited Acquired
Increased
(>3.4%)
-Thalassemia
heterozygosity
Deletional HPFH from
Vietnamese/South East
Asian
Hereditary high Hb A2
Unstable hemoglobin
Sickle cell trait
Sickle cell anemia
(particularly coexisting
-thalassemia)
Hb S/0-thalassemia
Congenital
dyserythropoietic anemia
(some cases)
Heterozygosity for other
-chain variants
Thyrotoxicosis
HIV infection
Zidovudine therapy
Megaloblastic
anemia (some cases)
Decreased
(<2.2%)
-thalassemia: +
homozygosity, a0
heterozygosity, and HbH
disease
Deletional HPFH (except
Vietnamese/South East
Asian type)
 and A-thalassemia
heterozygosity (some cases)
-Thalassemia
Hemoglobin Lepore
Hemoglobin Kenya
Severe iron
deﬁciency
Anemia of chronic
disease
Sideroblastic anemia
Lead poisoning
Juvenile
myelomonocytic
leukemia
Acquired Hb H
disease
Acute myeloid
leukemia (some
cases, particularly
erythroleukemia)
Aplastic anemia
(some cases)
Hypothyroidism
Chemotherapy-
induced increased
Hb F synthesis
Source: Modiﬁed from Bain et al.4
Hb A2 – hemoglobin A2; HPFH: hereditary persistence of
fetal hemoglobin; HIV: human immunodeﬁciency virus; HbH:
r
1
1
1
1
population of Rio Grande do Norte, Brazil. Genet Mol  Biol.hemoglobin H; Hb F: hemoglobin F or fetal hemoglobin.
Brazil.16–18 Since SCA is considered a public health problem in
Brazil and due to the clinical signiﬁcance of -Thal in respect
to this anemia, diagnosis is important.19–21 However, diagnosis
is mainly achieved by molecular techniques that are expensive
and not easily accessible. It is also important to remember
that the co-inheritance of -Thal and SCA results in increased
levels of Hb A2 as measured by automated HPLC, and could
result in a misdiagnosis of S-Thal.4
There lies the importance of the paper entitled
“Hemoglobin A2 values quantiﬁed by high performance
liquid chromatography in patients with sickle cell disease,
and the inﬂuence of the presence of alpha-thalassemia”
written by Fonseca et al. and published in this edition of
the Revista Brasileira de Hematologia e Hemoterapia.22 The
authors demonstrate that Hb A2 was overestimated not only
1 2 0 1 5;3  7(5):287–289
in individuals with Hb S but also in patients with Hb C, and
that the Hb A2 level was inﬂuenced by the genotype of -Thal.
In conclusion, in a country with a high degree of mis-
cegenation such as Brazil, not only the diagnosis of double
heterozygous states, such as S-Thal, but also the diagnosis of
co-inheritance of SCA with -Thal should be carried out care-
fully, taking into consideration the limitations of the available
laboratory techniques. Family studies or DNA analysis, when
possible, are desirable to conﬁrm the correct diagnosis.
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